WST — West Pharmaceutical Services Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for West Pharmaceutical Services, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	616	763	894	854	485
Net Total Accounts Receivable
Net Total Receivables	385	489	507	512	576
Total Inventory
Total Other Current Assets
Total Current Assets	1,374	1,742	1,920	1,936	1,538
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,012	1,127	1,263	1,513	1,716
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,794	3,314	3,617	3,830	3,643
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	503	594	519	672	550
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	939	978	932	949	961
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	1,855	2,335	2,685	2,881	2,682
Total Liabilities & Shareholders' Equity	2,794	3,314	3,617	3,830	3,643
Total Common Shares Outstanding